SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 745,000 KRW | -1.32% |
|
-5.70% | -1.97% |
| May. 23 | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
| May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
Quotes 5-day view
End-of-day quote Korea S.E.| 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-27 | Today | 2024-05-27 | |
|---|---|---|---|---|---|---|
| Last | 777000 ₩ | 770000 ₩ | 751000 ₩ | 755000 ₩ | 745000 ₩ | 745,000 ₩ |
| Volume | 41 152 | 73 622 | 81 016 | 44 353 | 51 101 | 51 101 |
| Change | -0.26% | -0.90% | -2.47% | +0.53% | -1.32% | -1.32% |
| Opening | 781,000.00 | 773,000.00 | 763,000.00 | 754,000.00 | 754,000.00 | 754,000 |
| High | 787,000.00 | 779,000.00 | 766,000.00 | 759,000.00 | 755,000.00 | 755,000 |
| Low | 776,000.00 | 770,000.00 | 751,000.00 | 746,000.00 | 745,000.00 | 745,000 |
Performance
| 1 day | -1.32% | ||
| 1 week | -5.70% | ||
| Current month | -4.61% | ||
| 1 month | -3.25% | ||
| 3 months | -7.68% | ||
| 6 months | +5.97% | ||
| Current year | -1.97% | ||
| 1 year | -4.12% | ||
| 3 years | -8.81% | ||
| 5 years | +156.01% |
Volumes
marketsDaily volume
51 101
Avg. Volume 20 sessions
58 967
Avg. Volume 20 sessions KRW
43 930 415 000.00
Avg. Volume 20 sessions USD
32 244 924.61
Record volume 1
8 089 601
Record volume 2
7 156 671
Record volume 3
3 037 569
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
53 811 724 711 172
Capitalization (USD)
39 497 805 938
Net sales (KRW)
3 695
Net sales (USD)
3
Number of employees
4 284
Sales / Employee (KRW)
1
Sales / Employee (USD)
0
Free-Float
25.25 %
Free-Float capitalization (KRW)
13 589 938 850 118
Free-Float capitalization (USD)
9 975 015 116
Average Daily Capital Traded
0.08%
Highs and lows
1 week
745 000.00
787 000.00
1 month
745 000.00803 000.00
Current year
739 000.00880 000.00
1 year
668 000.00880 000.00
3 years
668 000.001 000 000.00
5 years
241 500.001 000 000.00
10 years
125 500.001 000 000.00
Indicators
Moving average 5 days
759 600.00
Moving average 20 days
775 850.00
Moving average 50 days
799 440.00
Moving average 100 days
798 790.00
Price spread / (MMA5)
+1.96%
Price spread / (MMA20)
+4.14%
Price spread / (MMA50)
+7.31%
Price spread / (MMA100)
+7.22%
STIM
RSI 9 days
26.19
RSI 14 days
32.03
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.32% | -5.70% | -1.97% | -4.12% | 39.5B | ||
| +0.47% | +1.46% | -1.64% | -7.30% | 90.28B | ||
| +0.21% | -4.40% | -15.88% | -27.13% | 31.71B | ||
| -0.70% | -0.90% | +61.28% | +54.06% | 26.41B | ||
| -1.75% | -3.96% | -22.96% | -14.84% | 14.34B | ||
| -0.37% | -0.64% | -9.17% | -7.82% | 12.89B | ||
| -1.62% | -0.35% | -11.77% | -2.45% | 11.8B | ||
| -0.36% | -5.11% | -45.97% | -32.13% | 10.95B | ||
| -0.14% | -0.93% | +3.30% | +21.39% | 8.85B | ||
| +1.80% | -8.34% | -13.92% | -2.52% | 7.53B | ||
| -2.00% | -2.11% | +88.83% | +307.45% | 7.41B | ||
| 0.00% | -2.22% | -8.52% | +10.24% | 6.92B | ||
| -2.88% | -3.98% | -9.57% | +2.79% | 6.55B | ||
| -0.42% | -3.15% | -11.50% | +4.42% | 6.48B | ||
| -0.60% | -5.50% | -39.54% | -18.78% | 6.15B | ||
| -1.31% | -5.77% | -31.66% | +103.77% | 5.23B | ||
| Average | -0.63% | -2.69% | -4.42% | +24.19% | ||
| Weighted average by Cap. | -0.36% | -1.69% | -0.76% | +6.98% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -1.97% | ||
| 2023 | -7.43% | ||
| 2022 | -9.08% | ||
| 2021 | +9.32% | ||
| 2020 | +90.76% | ||
| 2019 | +12.03% | ||
| 2018 | +4.18% | ||
| 2017 | +145.70% | ||
| 2016 | +4.86% |
- Stock Market
- Equities
- A207940 Stock
- Quotes Samsung Biologics Co.,Ltd.
